DE602005006815D1 - 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung - Google Patents
2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendungInfo
- Publication number
- DE602005006815D1 DE602005006815D1 DE602005006815T DE602005006815T DE602005006815D1 DE 602005006815 D1 DE602005006815 D1 DE 602005006815D1 DE 602005006815 T DE602005006815 T DE 602005006815T DE 602005006815 T DE602005006815 T DE 602005006815T DE 602005006815 D1 DE602005006815 D1 DE 602005006815D1
- Authority
- DE
- Germany
- Prior art keywords
- phenylthiazol
- carbamide
- derivatives
- preparation
- therapeutic uses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0407695A FR2872813B1 (fr) | 2004-07-09 | 2004-07-09 | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
PCT/FR2005/001729 WO2006016039A1 (fr) | 2004-07-09 | 2005-07-05 | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005006815D1 true DE602005006815D1 (de) | 2008-06-26 |
Family
ID=34948475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005006815T Active DE602005006815D1 (de) | 2004-07-09 | 2005-07-05 | 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung |
Country Status (26)
Country | Link |
---|---|
US (1) | US7767681B2 (de) |
EP (1) | EP1771425B1 (de) |
JP (1) | JP2008505872A (de) |
KR (1) | KR20070030271A (de) |
CN (1) | CN101001847A (de) |
AR (1) | AR054397A1 (de) |
AT (1) | ATE395342T1 (de) |
AU (1) | AU2005271130A1 (de) |
BR (1) | BRPI0513184A (de) |
CA (1) | CA2571143A1 (de) |
CR (1) | CR8824A (de) |
DE (1) | DE602005006815D1 (de) |
EA (1) | EA011076B1 (de) |
EC (1) | ECSP067110A (de) |
ES (1) | ES2304719T3 (de) |
FR (1) | FR2872813B1 (de) |
IL (1) | IL180284A0 (de) |
MA (1) | MA28734B1 (de) |
MX (1) | MX2007000367A (de) |
NO (1) | NO20070224L (de) |
PE (1) | PE20060487A1 (de) |
TN (1) | TNSN06439A1 (de) |
TW (1) | TW200621737A (de) |
UY (1) | UY29007A1 (de) |
WO (1) | WO2006016039A1 (de) |
ZA (1) | ZA200700705B (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004228028B2 (en) | 2003-04-03 | 2009-12-10 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
FR2854158B1 (fr) | 2003-04-25 | 2006-11-17 | Sanofi Synthelabo | Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique |
CA2559665A1 (en) | 2004-03-16 | 2005-09-29 | The Regents Of The University Of California | Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
FR2876692B1 (fr) | 2004-10-19 | 2007-02-23 | Sanofi Aventis Sa | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique |
CN101084216B (zh) | 2004-10-20 | 2011-09-14 | 加利福尼亚大学董事会 | 可溶性环氧化物水解酶的改进抑制剂 |
GB0428327D0 (en) * | 2004-12-24 | 2005-02-02 | Astrazeneca Ab | Method |
BRPI0519288A2 (pt) | 2004-12-24 | 2009-01-06 | Astrazeneca Ab | compostos heterocÍclicos como antagonistas de ccr2b |
US8067415B2 (en) * | 2005-11-01 | 2011-11-29 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of CCR2 |
US20100016289A1 (en) * | 2005-11-01 | 2010-01-21 | Kevin Sprott | Compounds Useful as Antagonists of CCR2 |
US8067457B2 (en) * | 2005-11-01 | 2011-11-29 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of CCR2 |
FR2895989B1 (fr) | 2006-01-06 | 2010-04-30 | Sanofi Aventis | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
TW200808723A (en) * | 2006-03-13 | 2008-02-16 | Univ California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
US7935715B2 (en) | 2006-07-28 | 2011-05-03 | Boehringer Ingelheim International Gmbh | Compounds which modulate the CB2 receptor |
MX2009002888A (es) | 2006-09-25 | 2009-03-31 | Boehringer Ingelheim Int | Compuestos que modulan el receptor cb2. |
US8173638B2 (en) * | 2006-11-21 | 2012-05-08 | Boehringer Ingelheim International Gmbh | Compounds which modulate the CB2 receptor |
WO2008120759A1 (ja) * | 2007-03-30 | 2008-10-09 | Japan Tobacco Inc. | ウレア化合物およびその用途 |
JP5492092B2 (ja) | 2007-11-07 | 2014-05-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節する化合物 |
JP5749162B2 (ja) | 2008-07-10 | 2015-07-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節するスルホン化合物 |
KR20110063438A (ko) | 2008-09-25 | 2011-06-10 | 베링거 인겔하임 인터내셔날 게엠베하 | Cb2 수용체를 선택적으로 조절하는 설포닐 화합물 |
US8299103B2 (en) | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
EP2443107B1 (de) | 2009-06-16 | 2018-08-08 | Boehringer Ingelheim International GmbH | Azetidin 2 -carboxamidderivate als cb2-rezeptormodulatoren |
EP2480544A1 (de) | 2009-09-22 | 2012-08-01 | Boehringer Ingelheim International GmbH | Verbindungen für selektive cb2-rezeptormodulation |
US9315454B2 (en) | 2010-01-15 | 2016-04-19 | Boehringer Ingelheim International Gmbh | Compounds which modulate the CB2 receptor |
WO2012054093A2 (en) | 2010-01-29 | 2012-04-26 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
JP5746228B2 (ja) | 2010-03-05 | 2015-07-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を選択的に調節するテトラゾール化合物 |
CA2793311C (en) | 2010-03-17 | 2019-01-15 | Taivex Therapeutics Inc. | Modulators of hec1 activity and methods therefor |
WO2012012307A1 (en) | 2010-07-22 | 2012-01-26 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which modulate the cb2 rece |
US11071736B2 (en) | 2011-11-21 | 2021-07-27 | Taivex Therapeutics Corporation | Modulators of HEC1 activity and methods therefor |
EP2803668A1 (de) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Neuartige (Cyano-dimethyl-methyl)-isoxazole und -[1,3,4]-thiadiazole |
CN112279748A (zh) * | 2020-12-24 | 2021-01-29 | 浙江巨化技术中心有限公司 | 一种1,1,2,2-四氟乙烷的制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2406634A1 (fr) | 1977-10-19 | 1979-05-18 | Fabre Sa Pierre | Immunostimulants derives d'amino thiazoles |
WO1987001706A2 (en) | 1985-09-12 | 1987-03-26 | The Upjohn Company | C20 through c26 amino steroids |
FR2677356B1 (fr) * | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
WO1993000342A1 (en) | 1991-06-21 | 1993-01-07 | Boehringer Mannheim Italia S.P.A. | 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract |
FR2701708B1 (fr) | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
CO4970713A1 (es) | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen |
US6506751B1 (en) * | 1999-11-12 | 2003-01-14 | Millennium Pharmaceuticals, Inc. | Thiazolidinone compounds useful as chemokine inhibitors |
US6852752B2 (en) * | 1999-12-17 | 2005-02-08 | Vicuron Pharmaceuticals Inc. | Urea compounds, compositions and methods of use and preparation |
US6797820B2 (en) * | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
EP1344525A4 (de) | 2000-12-22 | 2005-05-25 | Ishihara Sangyo Kaisha | Anilinderivate oder ihre salze und diese enthaltende zytokinproduktion-inhibitoren |
US7265134B2 (en) * | 2001-08-17 | 2007-09-04 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
US7157452B2 (en) | 2001-12-31 | 2007-01-02 | Mgi Gp, Inc. | Substituted 4,9-dihydrocyclopenta{imn}phenanthridine-5-ones derivatives thereof and their uses |
TW200403058A (en) | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
WO2003104230A1 (ja) | 2002-06-07 | 2003-12-18 | 協和醱酵工業株式会社 | 二環性ピリミジン誘導体 |
FR2854158B1 (fr) * | 2003-04-25 | 2006-11-17 | Sanofi Synthelabo | Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique |
JP2006525312A (ja) * | 2003-04-28 | 2006-11-09 | アブ サイエンス | 脳虚血を治療するためのチロシンキナーゼ阻害剤の使用方法 |
FR2876692B1 (fr) | 2004-10-19 | 2007-02-23 | Sanofi Aventis Sa | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique |
BRPI0519288A2 (pt) | 2004-12-24 | 2009-01-06 | Astrazeneca Ab | compostos heterocÍclicos como antagonistas de ccr2b |
FR2895989B1 (fr) | 2006-01-06 | 2010-04-30 | Sanofi Aventis | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
-
2004
- 2004-07-09 FR FR0407695A patent/FR2872813B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-05 EP EP05786078A patent/EP1771425B1/de active Active
- 2005-07-05 ZA ZA200700705A patent/ZA200700705B/xx unknown
- 2005-07-05 ES ES05786078T patent/ES2304719T3/es active Active
- 2005-07-05 AU AU2005271130A patent/AU2005271130A1/en not_active Abandoned
- 2005-07-05 WO PCT/FR2005/001729 patent/WO2006016039A1/fr active IP Right Grant
- 2005-07-05 KR KR1020077000499A patent/KR20070030271A/ko not_active Application Discontinuation
- 2005-07-05 MX MX2007000367A patent/MX2007000367A/es not_active Application Discontinuation
- 2005-07-05 CA CA002571143A patent/CA2571143A1/fr not_active Abandoned
- 2005-07-05 JP JP2007519837A patent/JP2008505872A/ja active Pending
- 2005-07-05 BR BRPI0513184-7A patent/BRPI0513184A/pt not_active IP Right Cessation
- 2005-07-05 CN CNA2005800269784A patent/CN101001847A/zh active Pending
- 2005-07-05 EA EA200700096A patent/EA011076B1/ru not_active IP Right Cessation
- 2005-07-05 AT AT05786078T patent/ATE395342T1/de not_active IP Right Cessation
- 2005-07-05 DE DE602005006815T patent/DE602005006815D1/de active Active
- 2005-07-07 UY UY29007A patent/UY29007A1/es not_active Application Discontinuation
- 2005-07-07 AR ARP050102818A patent/AR054397A1/es unknown
- 2005-07-08 PE PE2005000797A patent/PE20060487A1/es not_active Application Discontinuation
- 2005-07-11 TW TW094123449A patent/TW200621737A/zh unknown
-
2006
- 2006-12-21 CR CR8824A patent/CR8824A/es not_active Application Discontinuation
- 2006-12-24 IL IL180284A patent/IL180284A0/en unknown
- 2006-12-26 EC EC2006007110A patent/ECSP067110A/es unknown
- 2006-12-26 TN TNP2006000439A patent/TNSN06439A1/fr unknown
-
2007
- 2007-01-02 MA MA29605A patent/MA28734B1/fr unknown
- 2007-01-03 US US11/649,316 patent/US7767681B2/en not_active Expired - Fee Related
- 2007-01-12 NO NO20070224A patent/NO20070224L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101001847A (zh) | 2007-07-18 |
EA011076B1 (ru) | 2008-12-30 |
MA28734B1 (fr) | 2007-07-02 |
ECSP067110A (es) | 2007-01-26 |
TNSN06439A1 (fr) | 2008-02-22 |
MX2007000367A (es) | 2007-03-27 |
EA200700096A1 (ru) | 2007-06-29 |
FR2872813B1 (fr) | 2007-01-19 |
NO20070224L (no) | 2007-04-02 |
ZA200700705B (en) | 2008-06-25 |
ES2304719T3 (es) | 2008-10-16 |
BRPI0513184A (pt) | 2008-04-29 |
AU2005271130A1 (en) | 2006-02-16 |
EP1771425A1 (de) | 2007-04-11 |
KR20070030271A (ko) | 2007-03-15 |
ATE395342T1 (de) | 2008-05-15 |
IL180284A0 (en) | 2007-07-04 |
JP2008505872A (ja) | 2008-02-28 |
CA2571143A1 (fr) | 2006-02-16 |
PE20060487A1 (es) | 2006-07-06 |
CR8824A (es) | 2007-08-28 |
US20070179126A1 (en) | 2007-08-02 |
FR2872813A1 (fr) | 2006-01-13 |
WO2006016039A1 (fr) | 2006-02-16 |
US7767681B2 (en) | 2010-08-03 |
UY29007A1 (es) | 2006-02-24 |
EP1771425B1 (de) | 2008-05-14 |
TW200621737A (en) | 2006-07-01 |
AR054397A1 (es) | 2007-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005006815D1 (de) | 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung | |
DE602005002470D1 (de) | 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung | |
DE502005002105D1 (de) | 4-benzimidazol-2-yl-pyridazin-3-on-derivative, ihre herstellung und verwendung in arzneimitteln | |
ATE467633T1 (de) | 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung | |
DE602005019743D1 (de) | Oxopiperidinderivate, ihre herstellung und therapeutische verwendung | |
DE50312295D1 (de) | 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel | |
ATE502035T1 (de) | 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung | |
DE502005006424D1 (de) | Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel | |
ATE294171T1 (de) | Phenylsulfonyl-1,3-dihydro-2h-indol-2-on derivate,deren herstellung und deren therapeutische verwendung | |
ATE417846T1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
DE60323754D1 (de) | Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung | |
ATE542806T1 (de) | Diarylmethylpiperazinderivate, deren herstellung und deren verwendung | |
ATE512970T1 (de) | Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung | |
DE60303440D1 (de) | Benzoxazinonderivate, deren herstellung und deren verwendung als medikamente | |
DE602006005246D1 (de) | Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung | |
DE602004017463D1 (de) | Diphenylpyridinderivate, deren herstellung und deren therapeutische anwendung | |
DE60307632D1 (de) | Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung | |
ATE312828T1 (de) | Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung | |
DE502005006380D1 (de) | Neue cycloalkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel | |
DE602006015675D1 (de) | 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung | |
DE60321372D1 (de) | 3-phenylpyridoindolderivate, ihre herstellung und verwendung | |
ATE520654T1 (de) | Polypyrrol-derivate, ihre herstellung und ihre therapeutische verwendung | |
DE602004015600D1 (de) | Neue imidazolderivative, deren herstellung und deren verwendung als medikament | |
DE602004030564D1 (de) | 2-substituierte phenyl-5,7-dialkyl-3,7-dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung | |
ATE499351T1 (de) | Aryl- und heteroaryl-ethyl-acylguanidinderivate, ihre herstellung und ihre therapeutische anwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |